Uroplasty Plans to Double Sales Force During F...( MINNEAPOLIS April 3 2008 /- Uropl...),Health

MINNEAPOLIS, April 3, 2008 /PRNewswire-FirstCall/ -- Uroplasty, Inc. (Amex: UPI), a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunction, today announced plans to double its U.S. sales force by the end of its fiscal 2009, which began on April 1, 2008.

"We have successfully launched our second generation Urgent PC(R) neuromodulation system in the U.S. and in fiscal 2008 built a domestic sales force that has generated significant year-to-date sales growth," said David Kaysen, President and CEO. "As a result of this strong performance, and with the opportunity to continue our revenue growth during fiscal 2009, we plan to double the number of U.S. sales representatives to 36 from a team of 18 employed as of March 31, 2008."

"Most of the additions to the sales team are expected to be in place during the first half of our fiscal 2009," Mr. Kaysen continued. "With this planned expansion, we project U.S. revenues to increase by more than 70% during fiscal 2009, with most of the impact from the new team members coming in the fourth fiscal quarter given the approximate six-month ramp we believe necessary for the new sales representatives to gain experience and build customer relationships. In the first fiscal quarter, we anticipate that our field sales managers will devote a significant portion of their time and effort to the reorganization of the sales territories and training of the new sales representatives. It is also important to note that we believe we have sufficient capital resources to execute our fiscal 2009 plan."

In order to efficiently manage the growth of the U.S. sales organization, Uroplasty also announced today the promotion of Bi
'/>"/>